Checkpoint Capital L.P. 13D and 13G filings for Pieris Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 1:12 pm Sale | 2023-12-31 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Checkpoint Capital L.P. | 0 0.000% | -61,731 (Position Closed) | Filing |
| 2023-06-09 5:40 pm Purchase | 2023-06-01 | 13G | Pieris Pharmaceuticals, Inc. PIRS | Checkpoint Capital L.P. | 61,731 6.000% | 61,731 (New Position) | Filing |